Cargando…
Identification of selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascade
RET (REarranged during Transfection) is a receptor tyrosine kinase, which plays pivotal roles in regulating cell survival, differentiation, proliferation, migration and chemotaxis. Activation of RET is a mechanism of oncogenesis in medullary thyroid carcinomas where both germline and sporadic activa...
Autores principales: | Watson, Amanda J., Hopkins, Gemma V., Hitchin, Samantha, Begum, Habiba, Jones, Stuart, Jordan, Allan, Holt, Sarah, March, H. Nikki, Newton, Rebecca, Small, Helen, Stowell, Alex, Waddell, Ian D., Waszkowycz, Bohdan, Ogilvie, Donald J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937820/ https://www.ncbi.nlm.nih.gov/pubmed/27429741 http://dx.doi.org/10.12688/f1000research.8724.2 |
Ejemplares similares
-
Anilinoquinazoline inhibitors of the RET kinase domain—Elaboration of the 7-position
por: Jordan, Allan M., et al.
Publicado: (2016) -
The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity
por: Newton, Rebecca, et al.
Publicado: (2016) -
Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores – A cautionary disclosure
por: Acton, Ben, et al.
Publicado: (2019) -
Dynamics robustness of cascading systems
por: Young, Jonathan T., et al.
Publicado: (2017) -
IncucyteDRC: An R package for the dose response analysis of live cell imaging data
por: Chapman, Philip J., et al.
Publicado: (2016)